利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

3 条记录 (耗时 0.015 秒)

    ENDOLYSIN OBPGPLYS
    1.
    发明申请
    ENDOLYSIN OBPGPLYS 审中-公开
    内罗毕OBPGPLYS

    公开(公告)号：US20150024469A1

    公开(公告)日：2015-01-22

    申请号：US14475900

    申请日：2014-09-03

    申请人： LYSANDO AG ,  KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D

    发明人： Yves BRIERS ,  Rob LAVIGNE ,  Maarten WALMAGH ,  Stefan MILLER

    IPC分类号： C12N9/36 ,  C07K14/195

    CPC分类号： C12N9/2462 ,  A01N43/50 ,  A23L3/3571 ,  A61K38/00 ,  A61K38/47 ,  C07K7/08 ,  C07K14/195 ,  C07K14/21 ,  C07K14/43518 ,  C07K2319/21 ,  C07K2319/55 ,  C12Q1/04 ,  C12Q1/34 ,  C12Y302/01017 ,  G01N2333/928

    摘要： The present invention relates to a polypeptide with an amino acid sequence according to SEQ ID NO: 1 and fragments or derivatives thereof. The present invention further relates to fusion proteins comprising said polypeptide and an additional peptide stretch fused to said polypeptide at the N- or C-terminus. Moreover, the present invention relates to nucleic acid molecules encoding said polypeptide or fusion protein, vectors comprising said nucleic acid molecules and host cells comprising either said nucleic acid molecules or said vectors. In addition, the present invention relates to said polypeptide or fusion protein for use as a medicament, in particular for the treatment or prevention of Gram-negative bacterial infections, as diagnostic means, as cosmetic substance or as sanitizing agent. The present invention also relates to the use of said polypeptide or fusion protein for the treatment or prevention of Gram-negative bacterial contamination of foodstuff, of food processing equipment, of food processing plants, of surfaces coming into contact with foodstuff, of medical devices, of surfaces in hospitals and surgeries. Furthermore, the present invention relates to a pharmaceutical composition comprising said polypeptide or fusion protein.

    摘要翻译： 本发明涉及具有根据SEQ ID NO：1的氨基酸序列及其片段或衍生物的多肽。 本发明还涉及包含所述多肽的融合蛋白和在N-或C-末端与所述多肽融合的另外的肽拉伸。 此外，本发明涉及编码所述多肽或融合蛋白的核酸分子，包含所述核酸分子的载体和包含所述核酸分子或所述载体的宿主细胞。 此外，本发明涉及用作药物的所述多肽或融合蛋白，特别是用于治疗或预防革兰氏阴性细菌感染，作为诊断手段，作为化妆品或消毒剂。 本发明还涉及所述多肽或融合蛋白用于治疗或预防食品的食品加工设备，食品加工厂，与食品接触的表面，医疗器械的革兰氏阴性细菌污染， 在医院和手术中的表面。 此外，本发明涉及包含所述多肽或融合蛋白的药物组合物。

    ANTIMICROBIAL AGENTS
    3.
    发明申请
    ANTIMICROBIAL AGENTS 审中-公开
    抗菌药物

    公开(公告)号：US20150118731A1

    公开(公告)日：2015-04-30

    申请号：US14535457

    申请日：2014-11-07

    申请人： LYSANDO AG ,  KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D

    发明人： Rob LAVIGNE ,  Stefan MILLER ,  Yves BRIERS ,  Guido VOLCKAERT ,  Maarten WALMAGH

    IPC分类号： A61K38/47 ,  C12N9/36

    CPC分类号： A61K38/47 ,  A61K38/00 ,  A61L2/00 ,  C07K14/005 ,  C07K14/4723 ,  C07K2319/00 ,  C07K2319/20 ,  C12N9/2462 ,  C12N9/503 ,  C12N15/52 ,  C12N15/62 ,  C12Y302/01017 ,  Y02A50/475 ,  Y02A50/478 ,  Y02A50/479

    摘要： The application relates to antimicrobial agents against Gram-negative bacteria, in particular to fusion proteins composed of an enzyme having the activity of degrading the cell wall of Gram-negative bacteria and a peptide stretch fused to the enzyme at the N- or C-terminus, as well as pharmaceutical compositions comprising the same. Moreover, it relates to nucleic acid molecules encoding such a fusion protein, vectors comprising said nucleic acid molecules and host cells comprising either said nucleic acid molecules or said vectors. In addition, it relates to such a fusion protein for use as a medicament, in particular for the treatment or prevention of Gram-negative bacterial infections, as diagnostic means or as cosmetic substance. The application also relates to the treatment or prevention of Gram-negative bacterial contamination of foodstuff, of food processing equipment, of food processing plants, of surfaces coming into contact with foodstuff, of medical devices, of surfaces in hospitals and surgeries.

    摘要翻译： 本申请涉及抗革兰氏阴性细菌的抗微生物剂，特别是由具有降解革兰氏阴性细菌细胞壁的活性的酶和在N-或C-末端与酶融合的肽拉伸组成的融合蛋白 ，以及包含其的药物组合物。 此外，其涉及编码这种融合蛋白的核酸分子，包含所述核酸分子的载体和包含所述核酸分子或所述载体的宿主细胞。 此外，它涉及用作药物，特别是用于治疗或预防革兰氏阴性细菌感染的这种融合蛋白，作为诊断手段或化妆品。 该应用还涉及食品加工设备，食品加工厂，与食品接触的表面，医疗器械，医院和手术中的表面的革兰氏阴性细菌污染的治疗或预防。